Thursday, 20 February 2020

Biologics News

  • Breast cancer boasts of highest drug pipeline'

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 08 Sep, 2014

    Singapore: Breast cancer therapeutics pipeline has higher innovation in first-in-class molecules, with many new technologies holding the potential to transform the clinical and commercial t...Read more

  • AbbVie aquires API manufacturing firm in Singapore

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 25 Nov, 2014

    Singapore: AbbVie, a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott, has acquired a small molecule active pharmaceutical ingredient (API) m...Read more

  • Test to detect bird flu mutants

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 03 Nov, 2014

    Singapore: Australian scientists have developed a new test that can detect bird flu mutation by distinguishing between birds that have been vaccinated against the H5N1 strain of influenza v...Read more

  • Ebola vaccine trial update

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 03 Oct, 2014

    Singapore: WHO, in consultation with over 70 experts, is assessing the status of two Ebola vaccine candidates for their safety and efficacy potential.The two candidate vaccines have clinica...Read more

  • Roche to acquire Santaris Pharma for $450 mn

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 05 Aug, 2014

    Singapore: Global biopharmaceutical firm, Roche, is all set to acquire Santaris Pharma, a Denmark based biopharmaceutical company, that has developed Locked Nucleic Acid (LNA) platform to s...Read more

  • Beike awaits CFDA nod for stem cell application

    Biologics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 14 Jul, 2014

    Singapore: China-based Beike Biotechnology has recieved Chinese Food and Drug Administration (CFDA) nod for filing the approval application for human umbilical cord (UC) derived mesenchymal...Read more

  • Danish firm, Aussie instiute to co-develop pathological drugs

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 08 Nov, 2013

    Singapore: Danish firm, Mirrx Therapeutics and Australia's Centenary Institute of Cancer Medicine and Cell Biology has formed a collaboration and commercialisation agreement, which formalis...Read more

  • WHO sets timeline for ebola vaccine

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 03 Oct, 2014

    Singapore: From September 29-30, 2014, WHO organized an expert consultation to assess the groundwork of ebola vaccine development and concluded with an expected milestone to develop and lau...Read more

  • BI to enhance investment in Austria

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 28 Dec, 2015

    Singapore: Boehringer Ingelheim plans to establish a new large-scale biopharmaceutical production facility for active ingredients manufactured using cell cultures in Vienna with a rough inv...Read more

  • China Cord Blood gets US accredition

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 02 Nov, 2015

    Singapore: Guangdong subsidiary of China Cord Blood Corporation, a provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services,...Read more

  • Asthma therapy market to touch $23.1 bn by 2023

    Biologics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 08 Sep, 2014

    Singapore: Asthma treatment market value will grow from approximately USD15.9 billion in 2013, across eight major countries including US, UK, France, Germany, Spain, Italy, Japan and Austra...Read more

  • Nanodiamonds can be an effective cancer drug carrier

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jan, 2015

    Singapore: A study led by the National University of Singapore (NUS) has found that attaching chemotherapy drug Epirubicin to nanodiamonds effectively eliminates chemoresistant cancer stem ...Read more

  • India firm launches biosimilar for autoimmune disease

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 10 Dec, 2014

    Singapore: India-based Zydus Cadila has launched the biosimilar of Adalimumab, indicated for the treatment of auto immune disorders such as rheumatoid arthritis, juvenile idiopathic arthrit...Read more

  • China Biologic to manufacture PCC at Shandong Taibang facility

    Biologics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 20 Oct, 2014

    Singapore: China Biologic Products, China-based biopharmaceutical company, has received China Food and Drug Administration (CFDA) approval for commercial manufacturing of human prothrombin ...Read more

  • NIH discovers new animal model for MERS testing

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 27 Aug, 2014

    Singapore: Researchers at the National Institute of Health (NIH) have found that immune responses instigated by MERS infection in humans and marmosets were very similar. They said that marm...Read more

  • Sanofi and Boehringer to manufacture biologics

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jan, 2015

    Singapore: Under the terms of the agreement, Sanofi will have access to Boehringer Ingelheim's capabilities in Biberach an der Riss, Germany, to transfer and manufacture therapeutic mAbs. ...Read more

  • Singapore invests in microbial detection technology firm

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 02 Sep, 2015

    Singapore: Singapore Economic Development Board has invested in Rapid Micro Biosystems, a provider of automated, non-destructive, rapid microbial detection, to expand its global commercial ...Read more

  • Study: Telomerase causes inflammation in cancer

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 22 Nov, 2012

    Singapore: A*STAR scientists have identified the enzyme, telomerase, as a cause of chronic inflammation in human cancers. Chronic inflammation is now recognized as a key underlying cause fo...Read more